Remove 2026 Remove Aging and mental health Remove Education
article thumbnail

The Psychiatric Pipeline in Review: Quarter 2, 2025

Psychiatric Times

MindMed initiated a phase 3 study of MM120 for major depressive disorder, with results expected in the second half of 2026. If approved, Bysanti could be available for sale in the US in 2026. Results are expected in 2026. Topline data from Part A of the study is expected to be released in the second half of 2026.

article thumbnail

Evidence-Based Parenting Books 2024

Behavioral Collective Podcast

Whether you are looking for advice for your own children or are an educator working in school or childcare, you’ll find something useful in this collection of titles. We’ve selected books that cover various perspectives within behavioral sciences, catering to different ages and parenting needs. 33) “Behavior happens for a reason.

article thumbnail

Season’s Greetings 2023 from the President

World Psychiatric Association (WPA)

According to the World Health Organization, War, armed conflict and other man-made or natural disasters cause profound distress and can in some cases ignite or inflame existing mental health conditions. Science, in this time of pessimism and possibly even resignation, is a key facilitator for achieving a better future for all.